COVID-19 research
Gene: TAP2
agree with green geneCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
YES- this is covered on our targeted exomeCreated: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Comment on list classification: More than 3 cases have been found where plausible disease causing mutations have been found in TAP2 in patients with Bare lymphocyte syndrome, type I/HLA-class I deficiency so changing the rating of this gene from Amber to Green.Created: 9 May 2018, 1:36 p.m.
In OMIM TAP2 is associated with Bare lymphocyte syndrome, type I, due to TAP2 deficiency and Wegener-like granulomatosis. de la Salle et al. (1994) (PMID: 7517574) reported that in a family from Morocco with bare lymphocyte syndrome type I 2 of the 5 children were homozygous for an arg253-to-stop mutation in the TAP2 gene. Moins-Teisserenc et al (1999) (PMID: 10560675) report 5 patients with a syndrome of chronic necrotising granulomatous lesions, small-vessel vasculitis, recurrent respiratory-tract infections, and development of bronchiectasis. A diagnosis of Wegener's granulomatosis was considered for each. All 5 patients had a severe decrease in cell surface expression of HLA class I molecules and defective expression of the TAP complex. 2 patients (patients 1 and 3) were homozygous for a deletion of an adenosine (A) at codon 326, which caused a frameshift and a premature stop codon. The parents of patient 1 were heterozyous and symptom free. A PubMed search found 2 more publications associating TAP2 with Bare lymphocyte syndrome, type I/HLA-class I deficiency. Matamoros et al (2001) (PMID:11529920) report a 22 year old patient diagnosed with HLA-class I deficiency. The patient was found to have a homozygous single point mutation that results in a premature stop codon. España et al 2010 (PMID:20083708) report a patient with Bare Lymphocyte Syndrome and a severe reduction in HLA I expression in the patient's lymphocytes. The patient also developed squamous cell carcinoma. A TAP2 missense mutation was detected leading to a premature stop at codon. Her mother and daughters were heterozygous for the mutated allele. More than 3 cases have been found where plausible disease causing mutations have been found in TAP2 in patients with Bare lymphocyte syndrome, type I/HLA-class I deficiency so rating this gene Green.Created: 9 May 2018, 1:34 p.m.
Comment on phenotypes: Added MIM number to Bare lymphocyte syndrome, type I, due to TAP2 deficiency and added Wegener-like granulomatosisCreated: 9 May 2018, 12:44 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Publications
Gene rating submitted by Kimberly Gilmour and Austen Worth on behalf of London North GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email 6th September the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Tracy Briggs, David Gokhale and Abigal Rousseau on behalf of North West GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email on 20th June the Specialist Test Group all agreed there is enough evidence to rate this gene Green.Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
OriginaI Metadata from IUIS classification table (February, 2018) downloaded 20180614. IUIS Genetic defect (original gene symbol in IUIS download): TAP2 .PanelApp HGNC gene symbol check: TAP2 . IUIS Disease: MHC class I deficiency . IUIS Inheritance: AR .T cells: N/A, .B cells: Normal, .IUIS Other affected cells: N/A. IUIS Associated features: Vasculitis, pyoderma gangrenosum. IUIS Major category: Immunodeficiencies affecting cellular and humoral immunity. IUIS Subcategory: Combined Immunodeficiencies Generally Less Profound than Severe Combined ImmunodeficiencyCreated: 2 Jul 2018, 10:35 a.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s)
GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.Created: 19 Apr 2018, 1:50 p.m.
Original metadata downloaded from ESID Registry. ESID_Gene_original: TAP2, PanelApp HGNC gene symbol check: TAP2, ESID classification: Main_category/ Sub_category/ PID_Diagnosis Combined immunodeficiencies / HLA class I deficiency / HLA class I deficiencyCreated: 17 Apr 2018, 12:29 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: TAP2, GRID_Gene_Symbol: TAP2, GRID_Transcript_ENS_Community submitted: ENST00000374899, GRID_Transcript_RefSeq: NM_000544.3, GRID_Transcript_ENS_used_on_Production: ENST00000374899Created: 17 Apr 2018, 12:12 p.m.
gene: TAP2 was added gene: TAP2 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,GOSH PID v.8.0,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: TAP2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TAP2 were set to 10560675; 11529920; 20083708; 7517574 Phenotypes for gene: TAP2 were set to Vasculitis, pyoderma gangrenosum; Bare lymphocyte syndrome, type I, due to TAP2 deficiency 604571; HLA class I deficiency; Immunodeficiencies affecting cellular and humoral immunity; Wegener-like granulomatosis